Evidence map›Paper›PMID 41287595›Full record

ReviewIranian biomedical journal2025

Persian Medicinal Plants as Antidiabetic Agents: Mechanisms and Evidence from Bench to Bedside .

Hasan Fallah Huseini, Masoud Haghighi, Saeed Kianbakht, Mojtaba Ziaee

Abstract readReview
In one paragraph

Review in Iranian biomedical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hasan Fallah HuseiniMedicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran.
Masoud HaghighiIranian Fisheries Science Research Institute (IFSRI), Coldwater Fishes Research Center (CFRC), Agriculture Research, Education and Extension Organization (AREEO), Tonekabon, Iran.
Saeed KianbakhtMedicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran.
Mojtaba ZiaeeMedicinal Plants Research Center, Maragheh University of Medical Sciences, Maragheh, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of medicinal plants by diabetic patients dates back to ancient times. In recent years, numerous reports have been published on the efficacy and safety of many medicinal plants in the treatment of diabetes through various mechanisms. This review highlights the up-to-date proposed mechanisms of action of the most common antidiabetic herbs used in Persian medicine, comprising Cinnamomum zeylanicum, Trigonella foenum-graecum, Urtica dioica, Nigella sativa, Citrullus colocynthis, Silybum marianum, Zingiber officinale, Punica granatum, Salvia officinalis, Vaccinium arctostaphylos, and Momordica charantia, with support from clinical and experimental studies. Clinical research has shown significant reductions in blood glucose levels and insulin resistance, as well as improvements in diabetes-related symptoms, including digestive disorders and lipid dysregulation, accompanied by negligible adverse effects. Continuing to study how these plants work and how effectively they treat diabetes is important for using these natural treatments in modern medicine, offering affordable and safe options for diabetes patients.

Indexed as

Diabetes MellitusHypoglycemic AgentsPlants, MedicinalAnimalsHumansPersiaPhytotherapyPlant ExtractsHypoglycemic AgentsPlant ExtractsDiabetes mellitusHypoglycemic agentsPersian medicinal plantsTraditional medicine

Identifiers

PMID41287595
PMCPMC13311365

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.